Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Seferovic, Jelena P ^a,c   Tesic, Milorad ^a,c   Seferovic, Petar M ^a,c   Lalic, Katarina ^a,c   Jotic, Aleksandra ^a,c   Biering Sørensen, Tor ^b   Giga, Vojislav ^a,c   Stankovic, Sanja ^a   Milic, Natasa ^c   Lukic, Ljiljana ^a,c   Milicic, Tanja ^a,c   MacEsic, Marija ^a,c   Gajovic, Jelena Stanarcic ^a   Lalic, Nebojsa M ^a,c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLICATION; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; VENTRICULAR FUNCTION, LEFT;

EID: 85040833326     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-19229-w     Document Type: Article

References (45)

1. Huxley, R., Barzi, F. & Woodward, M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: metaanalysis of 37 prospective cohort studies. BMJ. 332(7533), 73-8 (2006).
2. Kannel, W. B., Hjortland, M. & Castelli, W. P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 34, 29-34 (1974).
3. Pocock, S. J. et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 27, 65-75 (2006).
4. Skali, H. et al. Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study. Circ Heart Fail. 8(3), 448-54 (2015).
5. Heckbert, S. R. et al. Traditional cardiovascular risk factors in relation to left ventricular mass volume and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. J Am Coll Cardiol. 48, 2285-92 (2006).
6. Eguchi, K. et al. Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol. 101(12), 1787-91 (2008).
7. Fonseca, C. G. et al. Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction. Am J Cardiol. 94(11), 1391-5 (2004).
8. De Simone, G., Pasanisi, F. & Contaldo, F. Link of non-hemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension. 38, 13-8 (2001).
9. De Simone, G., Verdecchia, P., Pede, S., Gorini, M. & Maggioni, A. P. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension. 40, 470-6 (2002).
10. Kuperstein, R., Hanly, P., Niroumand, M. & Sasson, Z. The importance of age and obesity on the relation between diabetes and left ventricular mass. J Am Coll Cardiol. 37, 1957-62 (2001).
11. Jørgensen, P. G. et al. Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics. Diab Vasc Dis Res. 13(5), 321-30 (2016).
12. Redfield, M. M. et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 289, 194-202 (2003).
13. Srivastava, P. M. et al. Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes. Clin Sci. 114, 313-20 (2008).
14. Ichikawa, R. et al. Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 12, 38 (2013).
15. James, P. A. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 311(5), 507-20 (2014).
16. Levey, A. S. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 130, 461-70 (1999).
17. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28, 412-9 (1985).
18. Bruce, R. A. Exercise testing of patients with coronary heart disease. Ann Clin Res. 3, 323-30 (1971).
19. Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 16(3), 233-70 (2015).
20. Devereux, R. B. et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 57, 450-8 (1986).
21. Marwick, T. H. et al. Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 28(7), 727-54 (2015).
22. de Simone, G. et al. Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension. J Hypertens. 19, 119-25 (2001).
23. Tesic, M. et al. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy. J Cardiol. 70(4), 323-328 (2017).
24. Levelt, E. et al. Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes. Diabetes. 65(1), 44-52 (2016).
25. Liu, J. E. et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol. 37(7), 1943-9 (2001).
26. Velagaleti, R. S. et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging. 3, 257-63 (2010).
27. Coats, A. J. & Anker, S. D. Insulin resistance in chronic heart failure. J Cardiovasc Pharmacol. 35(Suppl 4), S9-14 (2000). 7.
28. Shah, R. V. et al. Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 61, 1698-706 (2013).
29. Sesti, G. et al. Characterization of left ventricular mass in individuals at risk for type 2 diabetes identified by HbA1c levels according to the American Diabetes Association criteria. Int J Cardiol. 179, 211-3 (2015).
30. Lieb, W. et al. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short-And long-term change in the Framingham Offspring Study. Circulation. 119(24), 3085-92 (2009).
31. Cheng, S. et al. Correlates of echocardiographic indices of cardiac remodeling over the adult life course longitudinal observations from the Framingham Heart Study. Circulation. 122, 570-8 (2010).
32. Joshi, D. et al. Continuous, noninvasive measurement of the haemodynamic response to submaximal exercise in patients with diabetes mellitus: evidence of impaired cardiac reserve and peripheral vascular response. Heart. 96, 36-41 (2010).
33. Scheuermann-Freestone, M. et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation. 107, 3040-6 (2003).
34. Larghat, A. M. et al. The microvascular effects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging. 15(12), 1368-76 (2014).
35. Van Hoeven, K. V. & Factor, S. M. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation. 82, 848-55 (1990).
36. Devereux, R. B. et al. Impact of diabetes on cardiac structure and function. The Strong Heart Study. Circulation. 101, 2271-6 (2000).
37. Haider, A. W., Larson, M. G., Benjamin, E. J. & Levy, D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 32, 1454-9 (1998).
38. Cioffi, G. et al. Inappropriate left ventricular mass independently predicts cardiovascular mortality in patients with type 2 diabetes. Int J Cardiol. 168(5), 4953-6 (2013).
39. Casale, P. N. et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 105, 173-8 (1986).
40. Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B. & Castelli, W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322, 1561-6 (1990).
41. Gardin, J. M. et al. M-mode echocardiographic predictors of six-to seven year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol. 87, 1051-7 (2001).
42. Rydén, L. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 34, 3035-87 (2013).
43. LJM, B.-deW. et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 55, 2154-62 (2012).
44. Young, L. H. et al. DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 301, 1547-55 (2009).
45. Fleischmann, K. E., Hunink, M. G., Kuntz, K. M. & Douglas, P. S. Exercise echocardiography or exercise SPECT imaging? A metaanalysis of diagnostic test performance. JAMA. 280(10), 913-20 (1998).